$BARK
Bark, Inc.

2023 Q4 Form 10-Q Financial Statement

#000181957423000042 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $125.1M $123.0M
YoY Change -6.89% -14.45%
Cost Of Revenue $47.83M $47.39M
YoY Change -11.66% -25.33%
Gross Profit $77.24M $75.64M
YoY Change -3.67% -5.85%
Gross Profit Margin 61.76% 61.48%
Selling, General & Admin $91.21M $86.70M
YoY Change -10.52% -3.11%
% of Gross Profit 118.08% 114.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.959M $3.070M
YoY Change 18.79% 306.62%
% of Gross Profit 3.83% 4.06%
Operating Expenses $91.21M $86.74M
YoY Change -10.52% -3.07%
Operating Profit -$13.97M -$11.10M
YoY Change -35.77% 21.35%
Interest Expense $902.0K $1.366M
YoY Change -28.75% 1.94%
% of Operating Profit
Other Income/Expense, Net $3.045M $132.0K
YoY Change 74.5% -186.27%
Pretax Income -$10.11M -$10.34M
YoY Change -52.48% -2.84%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.11M -$10.34M
YoY Change -52.48% -2.84%
Net Earnings / Revenue -8.08% -8.4%
Basic Earnings Per Share -$0.06 -$0.06
Diluted Earnings Per Share -$0.06 -$0.06
COMMON SHARES
Basic Shares Outstanding 179.3M shares 178.9M shares
Diluted Shares Outstanding 175.5M shares 177.0M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $131.3M $160.5M
YoY Change -20.04% -3.49%
Cash & Equivalents $131.3M $160.5M
Short-Term Investments
Other Short-Term Assets $4.430M $4.300M
YoY Change -40.96% -65.08%
Inventory $98.47M $109.4M
Prepaid Expenses
Receivables $6.500M $12.39M
Other Receivables $0.00 $0.00
Total Short-Term Assets $240.6M $286.6M
YoY Change -25.16% -19.63%
LONG-TERM ASSETS
Property, Plant & Equipment $27.21M $28.72M
YoY Change -32.11% -21.29%
Goodwill
YoY Change
Intangibles $11.79M $11.61M
YoY Change 203.45% 232.65%
Long-Term Investments
YoY Change
Other Assets $7.215M $7.271M
YoY Change 69.53% 64.43%
Total Long-Term Assets $79.99M $82.37M
YoY Change -6.8% -6.67%
TOTAL ASSETS
Total Short-Term Assets $240.6M $286.6M
Total Long-Term Assets $79.99M $82.37M
Total Assets $320.6M $369.0M
YoY Change -21.29% -17.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.59M $26.09M
YoY Change -6.17% -42.38%
Accrued Expenses $36.38M $35.50M
YoY Change -0.44% -4.49%
Deferred Revenue $29.00M $24.30M
YoY Change -11.85% -15.92%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $90.98M $85.96M
YoY Change -5.94% -22.78%
LONG-TERM LIABILITIES
Long-Term Debt $39.83M $81.59M
YoY Change -50.85% 6.64%
Other Long-Term Liabilities $700.0K $4.389M
YoY Change 32.58% -15.29%
Total Long-Term Liabilities $40.53M $85.98M
YoY Change -50.31% 5.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $90.98M $85.96M
Total Long-Term Liabilities $40.53M $85.98M
Total Liabilities $176.3M $218.0M
YoY Change -21.75% -10.91%
SHAREHOLDERS EQUITY
Retained Earnings -$342.0M -$331.8M
YoY Change 15.69% 20.96%
Common Stock $1.000K $1.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $144.3M $150.9M
YoY Change
Total Liabilities & Shareholders Equity $320.6M $369.0M
YoY Change -21.29% -17.05%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$10.11M -$10.34M
YoY Change -52.48% -2.84%
Depreciation, Depletion And Amortization $2.959M $3.070M
YoY Change 18.79% 306.62%
Cash From Operating Activities $15.03M $2.820M
YoY Change 195.96% -231.9%
INVESTING ACTIVITIES
Capital Expenditures $1.769M $1.960M
YoY Change -62.73% -120.91%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.769M -$1.960M
YoY Change -62.73% -79.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -42.37M -4.450M
YoY Change 1639.33% -860.68%
NET CHANGE
Cash From Operating Activities 15.03M 2.820M
Cash From Investing Activities -1.769M -1.960M
Cash From Financing Activities -42.37M -4.450M
Net Change In Cash -29.11M -3.590M
YoY Change 1283.04% -67.14%
FREE CASH FLOW
Cash From Operating Activities $15.03M $2.820M
Capital Expenditures $1.769M $1.960M
Free Cash Flow $13.26M $860.0K
YoY Change 3905.14% -88.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2020Q4 bark Class Of Warrant Or Right Number Of Warrants Called By Each Warrant Or Right Percentage
ClassOfWarrantOrRightNumberOfWarrantsCalledByEachWarrantOrRightPercentage
0.3333 shares
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10337000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10639000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10639000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26047000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26047000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177150161 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
177150161 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
170537000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22000000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
94000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
286000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
819000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4120000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
150947000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10639000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
742000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3852000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
200107000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
217061000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26047000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
896000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8195000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
200107000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26047000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5941000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4017000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2970000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2120000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2485000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-72000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
20000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
374000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
326000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
34000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
554000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6914000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8195000 usd
bark Increase Decrease In Inventory Reserves
IncreaseDecreaseInInventoryReserves
879000 usd
bark Increase Decrease In Inventory Reserves
IncreaseDecreaseInInventoryReserves
95000 usd
bark Fair Value Adjustment Of Warrants And Derivatives
FairValueAdjustmentOfWarrantsAndDerivatives
-1434000 usd
bark Fair Value Adjustment Of Warrants And Derivatives
FairValueAdjustmentOfWarrantsAndDerivatives
-4959000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5869000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8148000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14065000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7615000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
988000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
484000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
125000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
16000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6426000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14368000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3431000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2667000 usd
bark Proceeds From Tenant Improvement Allowance
ProceedsFromTenantImprovementAllowance
0 usd
bark Proceeds From Tenant Improvement Allowance
ProceedsFromTenantImprovementAllowance
1628000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1800000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1510000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
788000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
235000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7916000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19563000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4933000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
14108000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4933000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14108000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
106000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
310000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
94000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
896000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
286000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
819000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4120000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4665000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
586000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17459000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33083000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
183068000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
201679000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165609000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168596000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
160541000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166310000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5068000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2286000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165609000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168596000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
11000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2311000 usd
us-gaap Interest Paid Net
InterestPaidNet
75000 usd
us-gaap Interest Paid Net
InterestPaidNet
154000 usd
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 usd
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
24576000 usd
CY2023Q3 bark Number Of Product Lines
NumberOfProductLines
2 productline
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes estimates and assumptions about future events that affect the amounts reported in its condensed consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates, judgments and assumptions.</span>The Company bases its estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s condensed consolidated financial statements. The most significant estimates relate to determination of fair value of the Company’s allowance for uncollectible accounts receivable, excess and obsolete inventory reserve, stock-based compensation, stand-alone selling price of Direct to Consumer offerings and fair value of right-of-use assets. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and records adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates.
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2023Q3 bark Number Of Leases Secured By Letter Of Credit
NumberOfLeasesSecuredByLetterOfCredit
4 lease
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk and Major Customers and Suppliers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains cash and cash equivalents with one domestic financial institution of high credit quality. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s accounts receivable are derived from sales contracts with large retail customers. The Company maintains reserves for potential credit losses on customer accounts when deemed necessary.</span></div>
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
123036000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
143814000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243626000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
274964000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24300000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
27800000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
81594000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
81221000 usd
CY2021Q2 bark Share Based Compensation Arrangement By Share Based Payment Award Options Minimum Exercise Price Grant Date Fair Value Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMinimumExercisePriceGrantDateFairValuePercentage
1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1082500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.18
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3689000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3852000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6914000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8195000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34772000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
36892000 usd
CY2023Q3 bark Lease Right Of Use Asset
LeaseRightOfUseAsset
34772000 usd
CY2023Q1 bark Lease Right Of Use Asset
LeaseRightOfUseAsset
36892000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4831000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5484000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46094000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
47240000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
50925000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
52724000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
17000000.0 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1900000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
2300000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
3900000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
4500000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
123036000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
143814000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
243626000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
274964000 usd
bark Increase Decrease In Operating Leases
IncreaseDecreaseInOperatingLeases
2100000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000 usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
885000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
281000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1006000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-130000 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1038000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1434000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4959000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
132000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-153000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1715000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5965000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10337000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10337000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10639000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10639000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-22000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26047000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-26047000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
176975883 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176975883 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176463723 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
176463723 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
177150161 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
177150161 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175980473 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175980473 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
47394000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
63473000 usd
us-gaap Cost Of Revenue
CostOfRevenue
94948000 usd
us-gaap Cost Of Revenue
CostOfRevenue
118809000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
75642000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
80341000 usd
us-gaap Gross Profit
GrossProfit
148678000 usd
us-gaap Gross Profit
GrossProfit
156155000 usd
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001819574-23-000042-index-headers.html Edgar Link pending
0001819574-23-000042-index.html Edgar Link pending
0001819574-23-000042.txt Edgar Link pending
0001819574-23-000042-xbrl.zip Edgar Link pending
bark-20230930.htm Edgar Link pending
bark-20230930.xsd Edgar Link pending
exhibit311-section302certi.htm Edgar Link pending
exhibit312-section302certi.htm Edgar Link pending
exhibit313-section302certi.htm Edgar Link pending
exhibit321-section906certi.htm Edgar Link pending
exhibit322-section906certi.htm Edgar Link pending
exhibit323-section906certi.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
notespurchaseagreementdate.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
bark-20230930_cal.xml Edgar Link unprocessable
bark-20230930_def.xml Edgar Link unprocessable
bark-20230930_lab.xml Edgar Link unprocessable
bark-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bark-20230930_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending